Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 148

Results For "RAT"

10031 News Found

FDA clears Wave Neuroscience’s AI-guided brain stimulation platform for PTSD treatment
Medical Device | June 13, 2026

FDA clears Wave Neuroscience’s AI-guided brain stimulation platform for PTSD treatment

MeRT becomes one of the few FDA-cleared neuromodulation therapies for PTSD, using EEG biomarkers and AI to personalize treatment for patients with treatment-resistant symptoms


Rayat Bahra University, Shukra Pharma launch Rs. 10 lakh seed fund to back student startups
News | June 13, 2026

Rayat Bahra University, Shukra Pharma launch Rs. 10 lakh seed fund to back student startups

Partnership will provide funding, incubation, mentorship, and industry exposure for ventures in healthcare, pharmaceuticals, biotechnology, medical technology, and agriculture


Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor
People | June 13, 2026

Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor

Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders


Govt approval to KIHT as CRO expands India’s innovation capabilities
Clinical Trials | June 12, 2026

Govt approval to KIHT as CRO expands India’s innovation capabilities

KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation


Research must translate into real-world solutions: Dr. Jitendra Singh
Policy | June 12, 2026

Research must translate into real-world solutions: Dr. Jitendra Singh

Union Minister inaugurated a DST-funded Central Instrumentation Facility and three new research clusters focused on advanced materials, clean energy, and healthcare at IIT Gandhinagar


DuPont powers all UE healthcare manufacturing sites with 100% renewable electricity
Sustainability | June 12, 2026

DuPont powers all UE healthcare manufacturing sites with 100% renewable electricity

The milestone, announced from Wilmington, Delaware, is powered through additional Renewable Energy Certificates (RECs) and backed by US-sourced renewable generation


Ipca Labs, BRL to co-develop next-gen biologics for cancer and autoimmune diseases
News | June 12, 2026

Ipca Labs, BRL to co-develop next-gen biologics for cancer and autoimmune diseases

The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients


India’s pharma market to hit US$ 130 billion, exports US$ 80 billion by 2030: ASSOCHAM
News | June 12, 2026

India’s pharma market to hit US$ 130 billion, exports US$ 80 billion by 2030: ASSOCHAM

Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion


Biopharma SHAKTI envisages launch of 100 biologics by 2047:  Anupriya Patel
Policy | June 12, 2026

Biopharma SHAKTI envisages launch of 100 biologics by 2047: Anupriya Patel

The union minister spoke at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi


Major UK study to evaluate newborn screening for spinal muscular atrophy
Healthcare | June 12, 2026

Major UK study to evaluate newborn screening for spinal muscular atrophy

SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme